Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment.
about
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaCCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaSuppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.ZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-kB signaling.Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.NRAGE promotes the malignant phenotype of hepatocellular carcinoma.Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells.NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC.Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis.Systemic treatment for hepatocellular carcinoma: Still unmet expectationsUp regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition.Biomarkers in hepatocellular carcinoma: an overview.The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma.Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study.Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling NetworksThe PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers.Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination.TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer.Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma.Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome.CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage.Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers.Liver regeneration accelerates hepatitis B virus-related tumorigenesis of hepatocellular carcinoma.Oncogenic Signaling Induced by HCV InfectionTransforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
P2860
Q26772321-62DBADE4-C86E-475A-B971-08810EB39167Q26779818-0213D31A-3DA0-414D-A63F-1A342C49AE94Q26784412-5D710EBA-702E-416D-BDD2-8098054D8AECQ30009202-4FF2218C-9D1B-491F-B838-0DF0AD085844Q33849703-9191FBD0-5426-4FF2-9317-5BB7C714911FQ36028022-9863B7C3-622F-44E9-BA7E-3931142531FDQ36640154-A0294635-32A3-460A-83A7-2435DD409621Q37596811-34666BA2-31CF-40CA-8225-151E5FD98ABDQ37745263-4EF56776-6933-43C5-B121-6E22ED6620B9Q38416518-E9284EA1-62D1-4DAE-AF33-BE07078EE3F6Q38610336-425F2629-80C9-4E26-9FC5-E3FF14EA7409Q38895324-D18955B1-9605-48FF-A87A-833B22003182Q39112745-D5768D14-907C-460A-B897-4DC0926CE853Q39200404-81EE1D04-F617-4CF8-BC58-E75C03BFC288Q39202758-77736262-4C3B-48A2-A1F5-BE15A664F58EQ40694579-7087F5AC-707B-481F-8905-F0F0D886BD9AQ41084007-FFDBE5DC-3368-4BE7-9799-05C24C8C428DQ41582124-48CB190F-7A67-4B91-A03D-2319845698C0Q47160125-A645828F-530E-4945-9DB8-6F139A7E7340Q47165141-9D2325BE-68FC-4D08-BBC2-E4BC068445D9Q50451829-C4B674D1-BBD5-498F-9492-2E59F085C017Q51496296-58C12C8B-8485-435D-B5C9-2F4CCFE44487Q52559212-CF3F8178-AAC6-405D-8382-B0B0765EF1E8Q52564717-72E284BE-D5EE-481A-97EB-987F36FEE840Q52668585-083F5CDB-93E8-4BD1-A4EC-9E15CA347B94Q53217212-D186CF90-EF54-40D0-8C57-FAFAE5B9B96BQ55216962-D396F880-E1D5-4C6A-AA14-48019EF0471FQ55227617-0E77DD9F-6667-4184-A91A-BE71595CCA46Q55502394-8A06E2B6-0B70-44D8-8219-70957B2BCAB1Q57050806-874295DC-87B0-4207-B80C-C833E3C572C8Q58754397-3090D5A2-C03C-490B-9021-B58C60AD1614
P2860
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Moving towards personalised th ...... role of the microenvironment.
@en
type
label
Moving towards personalised th ...... role of the microenvironment.
@en
prefLabel
Moving towards personalised th ...... role of the microenvironment.
@en
P2093
P2860
P1433
P1476
Moving towards personalised th ...... e role of the microenvironment
@en
P2093
Bhavna Rani
Francesco Dituri
P2860
P304
P356
10.1136/GUTJNL-2014-307323
P407
P577
2014-07-21T00:00:00Z